Filing Details
- Accession Number:
- 0001209191-15-009194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 20:51:57
- Reporting Period:
- 2015-01-30
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 20:51:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534275 | Anthony Mauro | 1000 Mylan Blvd Canonsburg PA 15317 | President, North America | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-30 | 108 | $22.66 | 78,044 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-01-30 | 3,132 | $23.44 | 81,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-01-30 | 379 | $30.90 | 81,555 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-30 | 3,619 | $53.73 | 77,936 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-02 | 5,656 | $30.90 | 83,592 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-02 | 5,656 | $52.87 | 77,936 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-03 | 3,980 | $30.90 | 81,916 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-03 | 3,980 | $53.01 | 77,936 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2015-01-30 | 108 | $0.00 | 108 | $22.66 |
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2015-01-30 | 3,132 | $0.00 | 3,132 | $23.44 |
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2015-01-30 | 379 | $0.00 | 379 | $30.90 |
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2015-02-02 | 5,656 | $0.00 | 5,656 | $30.90 |
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2015-02-03 | 3,980 | $0.00 | 3,980 | $30.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,757 | 2021-03-02 | No | 4 | M | Direct | |
| 4,266 | 2022-02-22 | No | 4 | M | Direct | |
| 12,872 | 2023-03-06 | No | 4 | M | Direct | |
| 7,216 | 2023-03-06 | No | 4 | M | Direct | |
| 3,236 | 2023-03-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,574 | Indirect | By 401(k) Plan |
Footnotes
- Represents acquisition of Mylan common stock upon exercise of stock options granted on March 2, 2011.
- Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012.
- Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013.
- Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on January 30, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 403,595 shares in transactions ranging from $53.01 to $54.00 with a weighted average price of $53.5684 as well as 205,341 shares in transactions ranging from $54.005 to $54.25 with a weighted average price of $54.0425. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
- Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 2, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 937,763 shares in transactions ranging from $52.23 to $53.22 with a weighted average price of $52.8646 as well as 13,957 shares in transactions ranging from $53.23 to $53.745 with a weighted average price of $53.5027. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
- Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 3, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 520,475 shares in transactions ranging from $52.50 to $53.25 with a weighted average price of $52.8739 as well as 149,400 shares at $53.50 and 1 share at $54.50. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
- This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014.
- These options vested in three equal installments on March 2, 2012, 2013, and 2014.
- Two-thirds of the options vested in equal installments on February 22, 2013 and 2014.
- One-third of the options vested on March 6, 2014.
Billionaire Hedge Funds
